Estija - estų - Ravimiamet

leyh pharma gmbh - propüültiouratsiil - tablett - 50mg 100tk

Estija - estų - Ravimiamet

tad pharma gmbh - atorvastatiin - õhukese polümeerikattega tablett - 40mg 84tk; 40mg 90tk; 40mg 4tk; 40mg 7tk; 40mg 98tk; 40mg 28tk; 40mg 30tk; 40mg 20tk; 40mg 100tk

Estija - estų - Ravimiamet

aop orphan pharmaceuticals gmbh - tetrabenasiin - tablett - 25mg 112tk

Estija - estų - Ravimiamet

chiesi pharmaceuticals gmbh - piroksikaam - tablett - 20mg 20tk

Estija - estų - Ravimiamet

woerwag pharma gmbh & co. kg - ramipriil - tablett - 5mg 10tk; 5mg 28tk; 5mg 100tk; 5mg 14tk; 5mg 98tk; 5mg 20tk; 5mg 30tk; 5mg 42tk

Estija - estų - Ravimiamet

woerwag pharma gmbh & co. kg - ramipriil - tablett - 10mg 28tk; 10mg 30tk; 10mg 42tk; 10mg 98tk; 10mg 50tk; 10mg 100tk; 10mg 10tk

Estija - estų - Ravimiamet

woerwag pharma gmbh & co. kg - ramipriil - tablett - 2,5mg 42tk; 2,5mg 20tk; 2,5mg 30tk; 2,5mg 28tk; 2,5mg 10tk; 2,5mg 98tk; 2,5mg 50tk

Europos Sąjunga - estų - EMA (European Medicines Agency)

krka, d.d., novo mesto - abirateroonatsetaat - eesnäärmevähk - endokriinset ravi - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Estija - estų - Ravimiamet

sandoz pharmaceuticals d.d. - abirateroon - õhukese polümeerikattega tablett - 1000mg 56tk; 1000mg 84tk; 1000mg 28tk; 1000mg 30tk; 1000mg 60tk

Estija - estų - Ravimiamet

sandoz pharmaceuticals d.d. - abirateroon - õhukese polümeerikattega tablett - 500mg 56tk; 500mg 84tk; 500mg 60tk; 500mg 112tk